Brennan Gray Medical Ltd SC796599 false 2024-01-25 2025-01-31 2025-01-31 The principal activity of the company is neurological services. Digita Accounts Production Advanced 6.30.9574.0 true SC796599 2024-01-25 2025-01-31 SC796599 2025-01-31 SC796599 bus:Director1 1 2025-01-31 SC796599 bus:Director2 1 2025-01-31 SC796599 core:RetainedEarningsAccumulatedLosses 2025-01-31 SC796599 core:ShareCapital 2025-01-31 SC796599 core:CurrentFinancialInstruments 2025-01-31 SC796599 core:CurrentFinancialInstruments core:WithinOneYear 2025-01-31 SC796599 core:OfficeEquipment 2025-01-31 SC796599 bus:SmallEntities 2024-01-25 2025-01-31 SC796599 bus:AuditExemptWithAccountantsReport 2024-01-25 2025-01-31 SC796599 bus:FilletedAccounts 2024-01-25 2025-01-31 SC796599 bus:SmallCompaniesRegimeForAccounts 2024-01-25 2025-01-31 SC796599 bus:RegisteredOffice 2024-01-25 2025-01-31 SC796599 bus:Director1 2024-01-25 2025-01-31 SC796599 bus:Director1 1 2024-01-25 2025-01-31 SC796599 bus:Director2 2024-01-25 2025-01-31 SC796599 bus:Director2 1 2024-01-25 2025-01-31 SC796599 bus:PrivateLimitedCompanyLtd 2024-01-25 2025-01-31 SC796599 bus:Agent1 2024-01-25 2025-01-31 SC796599 core:OfficeEquipment 2024-01-25 2025-01-31 SC796599 countries:Scotland 2024-01-25 2025-01-31 SC796599 bus:Director1 1 2024-01-24 SC796599 bus:Director2 1 2024-01-24 iso4217:GBP xbrli:pure

Registration number: SC796599

Brennan Gray Medical Ltd
trading as Brennanneurology Ltd
Unaudited Filleted Financial Statements
for the Period from 25 January 2024 to 31 January 2025

Brennan Gray Medical Ltd
trading as Brennanneurology Ltd

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 6
Accountants' Report | 7

Brennan Gray Medical Ltd
trading as Brennanneurology Ltd

Company Information

Directors | Dr Kathryn Mary Brennan Mr Robert Donald Gray

Registered office | Unit 4B Gateway Business Park Beancross Road Grangemouth Stirlingshire FK3 8WX

Accountants | EQ Accountants Ltd Unit 4B Gateway Business Park Beancross Road Grangemouth FK3 8WX

Brennan Gray Medical Ltd
trading as Brennanneurology Ltd

(Registration number: SC796599)
Balance Sheet as at 31 January 2025

| Note | 2025 £
Fixed assets |  |
Tangible assets | 4 | 564
Current assets |  |
Stocks | 5 | 8,325
Debtors | 6 | 15,036
Cash at bank and in hand |  | 6,272
|  | 29,633
Creditors: Amounts falling due within one year | 7 | (6,210)
Net current assets |  | 23,423
Net assets |  | 23,987
Capital and reserves |  |
Called up share capital |  | 100
Retained earnings |  | 23,887
Shareholders' funds |  | 23,987

For the financial period ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 2 October 2025 and signed on its behalf by:

......................................... Dr Kathryn Mary Brennan Director

Brennan Gray Medical Ltd
trading as Brennanneurology Ltd

Notes to the Unaudited Financial Statements for the Period from 25 January 2024 to 31 January 2025

1 | General information

The company is a private company limited by share capital, incorporated in Scotland.

2 | Accounting policies

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Office Equipment | 33% Straight Line

Brennan Gray Medical Ltd
trading as Brennanneurology Ltd

Notes to the Unaudited Financial Statements for the Period from 25 January 2024 to 31 January 2025

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Financial instruments

Classification
Financial instruments are classified and accounted for, according to the substance of the contractual
arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any
contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

3 | Employees and Directors

The average number of persons employed by the company (including directors) during the period, was 2.

Brennan Gray Medical Ltd
trading as Brennanneurology Ltd

Notes to the Unaudited Financial Statements for the Period from 25 January 2024 to 31 January 2025

4 | Tangible assets

| Office equipment £ | Total £
Cost or valuation
Additions | 842 | 842
At 31 January 2025 | 842 | 842
Depreciation
Charge for the period | 278 | 278
At 31 January 2025 | 278 | 278
Carrying amount
At 31 January 2025 | 564 | 564

5 | Stocks

| 2025 £
Work in progress | 8,325

6 | Debtors

Current | 2025 £
Trade debtors | 11,138
Other debtors | 3,898
| 15,036

7 | Creditors

Creditors: amounts falling due within one year

| 2025 £
Due within one year |
Taxation and social security | 6,210

Brennan Gray Medical Ltd
trading as Brennanneurology Ltd

Notes to the Unaudited Financial Statements for the Period from 25 January 2024 to 31 January 2025

8 | Related party transactions

Transactions with directors Debtors include the following amounts which are owed from individuals who were directors of the company during the year:

2025 | At 25 January 2024 £ | Advances to director £ | At 31 January 2025 £
Dr Kathryn Mary Brennan
Loan | - | 1,949 | 1,949
Mr Robert Donald Gray
Loan | - | 1,949 | 1,949

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Brennan Gray Medical Ltd
trading as Brennanneurology Ltd
for the Period Ended 31 January 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Brennan Gray Medical Ltd for the period ended 31 January 2025 as set out on pages 2 to 6 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of ICAS, we are subject to its ethical and other professional requirements which are detailed at http://www.icas.com/accountspreparationguidance.

This report is made solely to the Board of Directors of Brennan Gray Medical Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Brennan Gray Medical Ltd and state those matters that we have agreed to state to the Board of Directors of Brennan Gray Medical Ltd, as a body, in this report in accordance with the requirements of ICAS as detailed at http://www.icas.com/accountspreparationguidance. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Brennan Gray Medical Ltd and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Brennan Gray Medical Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Brennan Gray Medical Ltd. You consider that Brennan Gray Medical Ltd is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the accounts of Brennan Gray Medical Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................
EQ Accountants Ltd
Unit 4B
Gateway Business Park
Beancross Road
Grangemouth
FK3 8WX

2 October 2025